Entera Bio to Participate in Upcoming Investor and Scientific Conferences
Provided By GlobeNewswire
Last update: Aug 20, 2024
JERUSALEM, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today announced that management will be participating in the following investor and scientific conferences:
